Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It is widely searched today as a “peptide therapy” or “growth hormone peptide,” but its regulatory history and modern compounded use need to be distinguished carefully.
What Is Sermorelin?
Sermorelin is a 29-amino-acid GHRH analog. Rather than supplying growth hormone directly, it acts at the pituitary gland to stimulate growth-hormone release.
Was Sermorelin FDA Approved?
Yes, historically. FDA records show that sermorelin acetate was marketed as Geref and received FDA approval for pediatric growth hormone deficiency. FDA records also show that the product was later withdrawn by the applicant, effective June 18, 2009. Modern compounded sermorelin should therefore not be described as the same thing as a currently marketed FDA-approved Geref product.
Why Is Sermorelin Marketed for Adults?
Today sermorelin is often promoted by wellness clinics for “growth hormone optimization,” sleep, recovery, body composition or anti-aging. Those marketing uses should not be confused with the historical pediatric indication. In adults, symptoms such as fatigue, poor recovery, low muscle mass or increased body fat are nonspecific and have many more common explanations.
Sermorelin vs. Growth Hormone Replacement
Sermorelin stimulates endogenous growth-hormone release, while recombinant human growth hormone directly supplies growth hormone. Neither should be used simply to raise hormone levels in otherwise healthy adults. Adult growth hormone deficiency requires a clinical diagnosis and appropriate endocrine testing.
Sermorelin vs. CJC-1295 and Ipamorelin
All three are discussed in the growth-hormone secretagogue market, but they are different compounds with different regulatory histories and evidence. CJC-1295 and ipamorelin have FDA-identified compounding safety concerns and are not FDA approved for anti-aging or general hormone optimization.
What Testing Is Used for Growth Hormone Disorders?
Random growth-hormone levels are generally not useful because secretion is pulsatile. Depending on the clinical context, IGF-1 and formal stimulation testing may be considered. Testing should be chosen based on the suspected disorder rather than ordered simply because a patient is interested in peptide therapy.
Sermorelin Near Me: What Should a Medical Evaluation Include?
Patients searching for sermorelin peptide near me or sermorelin treatment near me should ask about the exact product being used, whether it is FDA approved or compounded, the evidence for the proposed indication, possible adverse effects, product quality and whether a better-established treatment exists.
Related Resources
Read about peptide therapy in Los Angeles, CJC-1295 and ipamorelin, and growth hormone replacement therapy.
